Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
How did I sleep last night
This is according to new research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting by Elizabeth McDonald, a professor of radiology in Penns Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
In laboratory and pre-clinical settings, PT-141 (Bremelanotide) is studied as the defining CNS melanocortin agonist for sexual behaviour neuroscience and melanocortin receptor pharmacology: MC4R pharmacology receptor binding kinetics, Gs/cAMP/PKA signalling, hypothalamic expression mapping, and MC4R-selective research design Melanocortin receptor profiling MC1R/MC3R/MC4R/MC5R binding affinity, SAR studies, and MCR subtype selectivity research Central sexual behaviour neuroscience mPOA and PVN neuronal activation, c-Fos immunoreactivity, and hypothalamic circuit mapping Dopamine system modulation mPOA dopamine release, nucleus accumbens reward integration, and monoaminergic neurotransmitter crosstalk Oxytocin circuit activation PVN oxytocin neuron stimulation and affective/bonding dimension of sexual response HSDD research models female sexual desire deficiency models, melanocortin excitatory pathway engagement, and excitation/inhibition balance Erectile dysfunction research MC4R-mediated erectile pathway, PVN-corpus cavernosum neural connectivity, and PDE5-independent erection modelling CNS vs peripheral mechanism dissection central melanocortin pathway vs nitric oxide/PDE5 axis
Unlocking Holistic Weight Management: Introducing Seenu Blu The debut of GLP-1 medications in the realm of weight management certainly brings hope, but it's crucial to see it as a piece of a larger puzzle
What Medspas Should Do Now
Thats why you should always talk to your health care provider first to see if semaglutide is the right fit for your needs
